Johnson Investment Counsel’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $647K | Sell |
|
|||||
|
2025
Q2 | $604K | Buy |
|
|||||
|
2025
Q1 | $542K | Sell |
|
|||||
|
2024
Q4 | $473K | Buy |
|
|||||
|
2024
Q3 | $570K | Buy |
|
|||||
|
2024
Q2 | $437K | Sell |
|
|||||
|
2024
Q1 | $506K | Buy |
|
|||||
|
2023
Q4 | $369K | Sell |
|
|||||
|
2023
Q3 | $384K | Sell |
|
|||||
|
2023
Q2 | $420K | Sell |
|
|||||
|
2023
Q1 | $438K | Sell |
|
|||||
|
2022
Q4 | $461K | Buy |
|
|||||
|
2022
Q3 | $366K | Sell |
|
|||||
|
2022
Q2 | $684K | Buy |
|
|||||
|
2022
Q1 | $684K | Sell |
|
|||||
|
2021
Q4 | $712K | Sell |
|
|||||
|
2021
Q3 | $656K | Buy |
|
|||||
|
2021
Q2 | $652K | Sell |
|
|||||
|
2021
Q1 | $630K | Sell |
|
|||||
|
2020
Q4 | $684K | Sell |
|
|||||
|
2020
Q3 | $785K | Sell |
|
|||||
|
2020
Q2 | $860K | Buy |
|
|||||
|
2020
Q1 | $783K | Buy |
|
|||||
|
2019
Q4 | $892K | Sell |
|
|||||
|
2019
Q3 | $815K | Buy |
|
|||||
|
2019
Q2 | $755K | Buy |
|
|||||
|
2019
Q1 | $727K | Buy |
|
|||||
|
2018
Q4 | $660K | Buy |
|
|||||
|
2018
Q3 | $678K | Buy |
|
|||||
|
2018
Q2 | $677K | Buy |
|
|||||
|
2018
Q1 | $647K | Buy |
|
|||||
|
2017
Q4 | $580K | Sell |
|
|||||
|
2017
Q3 | $690K | Buy |
|
|||||
|
2017
Q2 | $731K | Sell |
|
|||||
|
2017
Q1 | $729K | Buy |
|
|||||
|
2016
Q4 | $295K | Sell |
|
|||||
|
2016
Q3 | $383K | Sell |
|
|||||
|
2016
Q2 | $412K | Sell |
|
|||||
|
2016
Q1 | $414K | Sell |
|
|||||
|
2015
Q4 | $484K | Buy |
|
|||||
|
2015
Q3 | $455K | Buy |
|
|||||
|
2015
Q2 | $335K | Buy |
|
|||||
|
2015
Q1 | $273K | Buy |
|
|||||
|
2014
Q4 | $238K | Buy |
|
|||||
|
2014
Q3 | $223K | Sell |
|
|||||
|
2014
Q2 | $491K | Buy |
|
|||||
|
2014
Q1 | $452K | Buy |
|
|||||
|
2013
Q4 | $309K | Buy |
|
|||||
|
2013
Q3 | $286K | Buy |
|
|||||
|
2013
Q2 | $234K | Buy |
|